# Andreas Birkedal Glenthoj, MD, PhD, Herlev, Denmark – FDA Inspections

Source: https://www.keypedia.com/companies/andreas-birkedal-glenthoj-md-phd/2ca2651c-3e0d-4fcf-8dfb-877a1544d8b6

> Inspection records and compliance data for Andreas Birkedal Glenthoj, MD, PhD in Herlev. 1 FDA inspection on record, last inspected October 08, 2021.

---

## Details

- Name: Andreas Birkedal Glenthoj, MD, PhD
- FEI Number: 3019695449
- Address Line 1: Herlev Ringvej 75, Herlev University Hospital, Department Of Hematology
- City: Herlev
- Country Name: Denmark
- Address: Herlev Ringvej 75, Herlev University Hospital, Department Of Hematology, Herlev, Denmark
- Country: Denmark

## Related Documents

- FDA Inspection 1154233 - Andreas Birkedal Glenthoj, MD, PhD - 2021-10-08 — classification: No Action Indicated (NAI), source: FDA, date: October 8, 2021

## Related Companies

- [Y-mAbs Therapeutics A/S](https://www.keypedia.com/companies/y-mabs-therapeutics-as/2909e299-cc6d-4730-b74a-d92230ef17de)
- [Helle Merete Staugaard, M.D.](https://www.keypedia.com/companies/helle-merete-staugaard-md/bf9e051f-32a5-4c1d-98f0-fe978e980376)
- [Anne-Sofie Krogsaa, MD](https://www.keypedia.com/companies/anne-sofie-krogsaa-md/532bc126-468a-43e6-9685-f79609a9b3e6)
- [Annesofie Krogsaa](https://www.keypedia.com/companies/annesofie-krogsaa/4a058a50-a10e-477f-954d-c3582c5095f7)
- [Dr. Christence Stubbe Teglbjaerg, CCBR](https://www.keypedia.com/companies/dr-christence-stubbe-teglbjaerg-ccbr/eaceb553-3a9f-408d-90ed-fa9fcf664aad)
- [Plum A/S](https://www.keypedia.com/companies/plum-as/925f8784-4767-4abd-94b2-e2f3378d37ed)
- [Mansoor Mirza](https://www.keypedia.com/companies/mansoor-mirza/2a9a0e88-b9d4-4912-a6ee-8a89ae1dfe86)
- [Per Rathenborg](https://www.keypedia.com/companies/per-rathenborg/a1ef5c5f-1e14-4f1e-8ed5-3f98876f7fc5)
- [Palle Jeppesen, M.D.](https://www.keypedia.com/companies/palle-jeppesen-md/0f2c76ca-6fc6-4a9b-ba16-fabffc9c96ac)
- [Evy Paulsen, Ph.D.](https://www.keypedia.com/companies/evy-paulsen-phd/e3a699c0-32bd-4344-999e-9b4a84ce44c2)